Drug Profile
NV 27
Alternative Names: NV-27Latest Information Update: 12 Dec 2017
Price :
$50
*
At a glance
- Originator Novogen
- Class Anti-inflammatories; Cardiovascular therapies; Isoflavones
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Coronary artery restenosis